Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Lavernia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Postgraduate Medicine|May 14, 2010
Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetesFrank Lavernia
The Journal of the American Osteopathic Association|July 21, 2010
Improving glycemic control and cardiometabolic risk through integrated treatment plansFrank Lavernia
Medscape Journal of Medicine|November 15, 2008
Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient careFrank Lavernia
Diabetes Technology & Therapeutics|June 15, 2011
What options are available when considering starting insulin: premix or basal?Frank Lavernia
Postgraduate Medicine|August 21, 2020
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placeboFrank Lavernia, Lawrence Blonde
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2018
A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULINRichard Dolinar, Frank Lavernia, Steven Edelman
Postgraduate Medicine|May 14, 2010
How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiationLouis Kuritzky, Benjamin J Epstein, Frank Lavernia
Postgraduate Medicine|December 17, 2020
Are residents receiving the training needed within their residency programs to optimally manage patients with diabetes?Javier Morales, Louis Kuritzky, Frank Lavernia, et al.
Postgraduate Medicine|October 7, 2015
Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goalsFrank Lavernia, Sarah E Adkins, Jay H Shubrook
Postgraduate Medicine|May 14, 2019
The non-medical switching of prescription medicationsRichard Dolinar, Christine G Kohn, Frank Lavernia, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Postgraduate Medicine|May 14, 2010
Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetesFrank Lavernia
The Journal of the American Osteopathic Association|July 21, 2010
Improving glycemic control and cardiometabolic risk through integrated treatment plansFrank Lavernia
Medscape Journal of Medicine|November 15, 2008
Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient careFrank Lavernia
Diabetes Technology & Therapeutics|June 15, 2011
What options are available when considering starting insulin: premix or basal?Frank Lavernia
Postgraduate Medicine|August 21, 2020
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placeboFrank Lavernia, Lawrence Blonde
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2018
A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULINRichard Dolinar, Frank Lavernia, Steven Edelman
Postgraduate Medicine|May 14, 2010
How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiationLouis Kuritzky, Benjamin J Epstein, Frank Lavernia
Postgraduate Medicine|December 17, 2020
Are residents receiving the training needed within their residency programs to optimally manage patients with diabetes?Javier Morales, Louis Kuritzky, Frank Lavernia, et al.
Postgraduate Medicine|October 7, 2015
Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goalsFrank Lavernia, Sarah E Adkins, Jay H Shubrook
Postgraduate Medicine|May 14, 2019
The non-medical switching of prescription medicationsRichard Dolinar, Christine G Kohn, Frank Lavernia, et al.
Pageof 2